Bidirectional changes in recorded pediatric asthma diagnoses with respiratory virus activity: A nationwide

Naomi Matsumoto1, Hisashi Ishida2, Shunsaku Hayase3

  • 1Department of Epidemiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.

Insights

Early-life respiratory infections may contribute to pediatric asthma. COVID-19 non-pharmaceutical interventions (NPIs) reduced respiratory viruses and asthma diagnoses, with asthma incidence rebounding as NPIs relaxed.

Area of Science:

  • Pediatric respiratory health
  • Epidemiology of infectious diseases
  • Asthma research

Background:

  • Early-life respiratory infections are linked to asthma development.
  • The role of respiratory viruses in asthma onset versus unmasking susceptibility is unclear.
  • The COVID-19 pandemic provided a natural experiment with non-pharmaceutical interventions (NPIs) suppressing and then allowing respiratory virus resurgence.

Purpose of the Study:

  • To investigate the association between population-level changes in respiratory virus activity and pediatric asthma diagnoses.
  • To examine the impact of COVID-19 NPIs and their relaxation on new pediatric asthma diagnoses.
  • To assess the role of specific respiratory pathogens in pediatric asthma incidence.

Main Methods:

  • A nationwide interrupted time-series study in Japan using health insurance claims data (approx. 99% population coverage).
  • Segmented negative binomial regression analyzed monthly asthma diagnoses in children under 19 (Jan 2018-Mar 2024), with atopic dermatitis as a negative control.
  • Analyses included age/sex stratification and ecological associations with specific pathogens.

Main Results:

  • Newly recorded pediatric asthma diagnoses significantly declined after NPI implementation (IRR 0.511) and rebounded after NPI relaxation (IRR 1.395).
  • Atopic dermatitis showed less pronounced changes, suggesting specificity to asthma.
  • Rate differences were most significant in infants (0-1 years) post-NPI and school-aged children (5-9 years) post-NPI relaxation. Rhinovirus, RSV, influenza, and M. pneumoniae correlated with asthma diagnoses.

Conclusions:

  • Pediatric asthma diagnoses exhibited bidirectional changes mirroring respiratory virus suppression and resurgence.
  • Findings support a potential contributory role of respiratory infections in pediatric asthma development.
  • Infants and school-aged children appear particularly susceptible to these effects.
Abstract

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...